GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » EDX Medical Group PLC (AQSE:EDX) » Definitions » EPS (Diluted)

EDX Medical Group (AQSE:EDX) EPS (Diluted) : £ (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is EDX Medical Group EPS (Diluted)?

EDX Medical Group's Earnings per Share (Diluted) for the six months ended in . 20 was £0.00.

EDX Medical Group's EPS (Basic) for the six months ended in . 20 was £0.00.

EDX Medical Group's EPS without NRI for the six months ended in . 20 was £0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


EDX Medical Group EPS (Diluted) Historical Data

The historical data trend for EDX Medical Group's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EDX Medical Group EPS (Diluted) Chart

EDX Medical Group Annual Data
Trend
EPS (Diluted)

EDX Medical Group Semi-Annual Data
EPS (Diluted)

Competitive Comparison of EDX Medical Group's EPS (Diluted)

For the Diagnostics & Research subindustry, EDX Medical Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EDX Medical Group's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, EDX Medical Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where EDX Medical Group's PE Ratio falls into.



EDX Medical Group EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

EDX Medical Group's Diluted EPS for the fiscal year that ended in . 20 is calculated as

Diluted EPS (A: . 20 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

EDX Medical Group's Diluted EPS for the quarter that ended in . 20 is calculated as



EDX Medical Group  (AQSE:EDX) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


EDX Medical Group EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of EDX Medical Group's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


EDX Medical Group (AQSE:EDX) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
210-211 Milton Road, Cambridge, GBR, CB4 0WA
EDX Medical Group Plc develops and validates digitally enabled diagnostic products and services to help predict disease risk, inform clinical decision-making and accelerate the development of new medicines in the areas of cancer, heart disease, neurology and infectious diseases.

EDX Medical Group (AQSE:EDX) Headlines

No Headlines